H Jadvar - Seminars in nuclear medicine, 2016 - Elsevier
The use of positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) in prostate cancer depends on the phase of the disease along the natural history of this …
O Martin, BM Schaarschmidt, J Kirchner… - Journal of nuclear …, 2020 - Soc Nuclear Med
Our purpose was to investigate differences between PET/MRI and PET/CT in lesion detection and classification in oncologic whole-body examinations and to investigate …
Background Bone scintigraphy (BS) is used to detect osseous metastases in osteosarcoma. 18F‐fluorodeoxyglucose‐positron emission tomography–computed tomography (18F‐FDG …
1Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 2Department of Radiology, Seoul St …
AM Karlberg, O Sæther, L Eikenes, PE Goa - EJNMMI physics, 2016 - Springer
Background Integrated clinical whole-body PET/MR systems were introduced in 2010. In order to bring this technology into clinical usage, it is of great importance to compare the …
J Grueneisen, BM Schaarschmidt, M Heubner… - European journal of …, 2015 - Elsevier
Objectives To compare the diagnostic competence of FAST-PET/MRI and PET/CT for whole- body staging of female patients suspect for a recurrence of a pelvic malignancy. Methods 24 …
T Sarabhai, BM Schaarschmidt, A Wetter… - European journal of …, 2018 - Springer
Purpose The aim of the present study was to assess and compare the diagnostic performance of integrated PET/MRI and MRI alone for local tumor evaluation and whole …
AC Sher, V Seghers, MJ Paldino… - American Journal of …, 2016 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to compare the diagnostic performance of sequential 18F-FDG PET/MRI (PET/MRI) and 18F-FDG PET/CT (PET/CT) in a pediatric …